The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 26

More JCP Articles

JCP
Omega-3 Fatty Acids for MDD With High Inflammation
Original Research

August 22, 2022

This study investigated whether dosage or inflammation levels affect response to omega-3s in MDD patients.
David Mischoulon, Boadie W. Dunlop, Becky Kinkead, et al
JCP
Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia
Insight videos

August 17, 2022

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that…
Christoph U. Correll, Zahinoor Ismail, Roger S. McIntyre, et al
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia
Academic Highlights

August 17, 2022

Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that…
Christoph U. Correll, Zahinoor Ismail, Roger S. McIntyre, et al
JCP
Thyroid Hormone Use in Mood Disorders
ASCP Corner

August 15, 2022

This ASCP Corner article reviews the potential benefits and harms of thyroid hormone therapy in the management of unipolar and bipolar depression.
Balwinder Singh, Vishnu Sundaresh
JCP
Intravenous Scopolamine Versus Active Placebo in MDD
Original Research

August 15, 2022

Scopolamine, an agent commonly used for motion sickness, has shown promise in treating depression. This study measured its efficacy in major depressive disorder versus an active placebo comparator.
Joseph C. C. Chen, Rachael L. Sumner, Venkat Krishnamurthy Naga, et al
JCP
Remission of Psychotic Late-Life Depression Following ECT
Original Research

August 10, 2022

In this study, ECT was associated with a significantly higher remission rate in psychotic versus nonpsychotic late-life depression.
Margot J. Wagenmakers, Mardien L. Oudega, Filip Bouckaert, et al
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
Insight videos

August 8, 2022

Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life…
Christoph U. Correll, Zahinoor Ismail, Roger S. McIntyre, et al
JCP
Faces Scales to Measure Anxiety and Anger
Original Research

August 8, 2022

Faces scales are used worldwide to assess pain. This study aimed to develop and evaluate measurement properties of faces scales to monitor the mental health symptoms of anxiety and…
Lisa Grossman Liu, David Russell, Meghan Reading Turchioe, et al
JCP
Very Low-Level Transcranial Photobiomodulation for MDD
Original Research

August 8, 2022

Transcranial photobiomodulation may be efficacious for major depressive disorder, but the optimal dose is not known. Here, a very low dose was studied to establish a threshold for lack…
Dan V. Iosifescu, Richard J. Norton, Umit Tural, et al
JCP
Cannabidiol for Treatment-Resistant Anxiety
Original Research

August 3, 2022

Treatment resistance affects nearly half of all young patients experiencing moderate-to-severe anxiety. This study investigated the safety and efficacy of cannabidiol for anxiety in young people who previously failed…
Maximus Berger, Emily Li, Simon Rice, et al
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
Academic Highlights

August 3, 2022

Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life…
Christoph U. Correll, Zahinoor Ismail, Roger S. McIntyre, et al
JCP
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics
Original Research

August 3, 2022

This study compared spontaneous reporting of tardive dyskinesia with long-acting injectable versus oral antipsychotics.
Fuminari Misawa, Yasuo Fujii, Hiroyoshi Takeuchi

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe